PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause
Xiukun Hou(Dalian Medical University), Xiangqian Zheng(Tianjin Medical University Cancer Institute and Hospital)
Cited by 7
Related Papers
2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma
|Cancer Biology and Medicine|2017|124